Insider · CIK 0001866861

Glezer Stanislav

Reports to the SEC for 1 company · GOLETA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001866861

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−32.6K sh	—	—	0
2024-05-01	INGNInogen IncM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	+32.6K sh	—	—	48,744
2024-05-01	INGNInogen IncF Tax Payment	EVP, R&D & Chief Med. Officer	FTax Payment	−16.7K sh	$7.05	−$118K	32,049
2024-03-01	INGNInogen Inc · Restricted Stock UnitA Award	EVP, R&D & Chief Med. Officer	AAward	+44K sh	—	—	43,993
2024-03-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−9,360 sh	—	—	18,719
2024-03-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−3,786 sh	—	—	3,787
2024-03-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−768 sh	—	—	4,612
2024-03-01	INGNInogen IncF Tax Payment	EVP, R&D & Chief Med. Officer	FTax Payment	−7,623 sh	$7.03	−$53.6K	16,106
2024-03-01	INGNInogen IncM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	+13.9K sh	—	—	23,729
2023-12-01	INGNInogen IncM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	+4,555 sh	—	—	12,146
2023-12-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−3,786 sh	—	—	3,787
2023-12-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−769 sh	—	—	5,380
2023-12-01	INGNInogen IncF Tax Payment	EVP, R&D & Chief Med. Officer	FTax Payment	−2,331 sh	$5.72	−$13.3K	9,815
2023-09-01	INGNInogen IncM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	+769 sh	—	—	7,985
2023-09-01	INGNInogen IncF Tax Payment	EVP, R&D & Chief Med. Officer	FTax Payment	−394 sh	$6.18	−$2,434.92	7,591
2023-09-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−769 sh	—	—	6,149
2023-06-01	INGNInogen IncM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	+768 sh	—	—	7,609
2023-06-01	INGNInogen IncF Tax Payment	EVP, R&D & Chief Med. Officer	FTax Payment	−393 sh	$10.37	−$4,075.41	7,216
2023-06-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−768 sh	—	—	6,918
2023-03-01	INGNInogen IncA Award	EVP, R&D & Chief Med. Officer	AAward	+2,272 sh	—	—	5,995
2023-03-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−3,787 sh	—	—	7,573
2023-03-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−769 sh	—	—	7,686
2023-03-01	INGNInogen IncF Tax Payment	EVP, R&D & Chief Med. Officer	FTax Payment	−2,568 sh	$15.56	−$40K	6,841
2023-03-01	INGNInogen IncM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	+4,556 sh	—	—	9,409
2023-03-01	INGNInogen IncF Tax Payment	EVP, R&D & Chief Med. Officer	FTax Payment	−1,142 sh	$15.56	−$17.8K	4,853
2023-02-28	INGNInogen Inc · Restricted Stock UnitA Award	EVP, R&D & Chief Med. Officer	AAward	+28.1K sh	—	—	28,079
2022-12-01	INGNInogen IncF Tax Payment	EVP, R&D & Chief Med. Officer	FTax Payment	−2,331 sh	$22.89	−$53.4K	3,723
2022-12-01	INGNInogen IncM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	+4,555 sh	—	—	6,054
2022-12-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−3,787 sh	—	—	7,573
2022-12-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−768 sh	—	—	8,455
2022-09-01	INGNInogen Inc · Restricted Stock UnitM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	−3,075 sh	—	—	9,223
2022-09-01	INGNInogen IncM Exercise/Conversion	EVP, R&D & Chief Med. Officer	MExercise/Conversion	+3,075 sh	—	—	3,075
2022-09-01	INGNInogen IncS Sale	EVP, R&D & Chief Med. Officer	SSale	−1,576 sh	$28.16	−$44.4K	1,499
2022-05-10	INGNInogen Inc · Restricted Stock UnitA Award	EVP, R&D & Chief Med. Officer	AAward	+32.6K sh	—	—	32,638
2022-03-01	INGNInogen Inc · Restricted Stock UnitA Award	EVP, R&D & Chief Med. Officer	AAward	+11.4K sh	—	—	11,360
2022-03-01	INGNInogen Inc · Restricted Stock UnitA Award	EVP, R&D & Chief Med. Officer	AAward	+11.4K sh	—	—	11,360
2021-08-09	INGNInogen Inc · Restricted Stock UnitA Award	EVP, R&D & Chief Med. Officer	AAward	+12.3K sh	—	—	12,298

Recent filings

Accepted (ET)
May 34
Glezer Stanislav0000950170-24-053100
SEC(opens sec.gov)
Mar 54
Glezer Stanislav0000950170-24-026541
SEC(opens sec.gov)
Dec 44
Glezer Stanislav0001209191-23-057302
SEC(opens sec.gov)
Sep 54
Glezer Stanislav0001209191-23-048238
SEC(opens sec.gov)
Jun 54
Glezer Stanislav0001209191-23-034376
SEC(opens sec.gov)
Mar 24
Glezer Stanislav0001209191-23-015041
SEC(opens sec.gov)

Companies

Inogen IncEVP, R&D & Chief Med. OfficerINGN

Address

C/O INOGEN, INC. 301 COROMAR DRIVE

GOLETA, CA, 93117